Sam Chai, Ph.D. serves as the Vice President of Clinical Strategy & Scientific Affairs at Ro, contributing expertise in consumer-facing diagnostic solutions and enterprise-level clinical strategy since January 2021. Previous roles at Ro include Vice President, Chief of Staff to the Chief Medical Officer, and Senior Director of Clinical Strategy and Special Projects, alongside a Director role focused on M&A and clinical development. Prior to Ro, Sam Chai was Manager of Corporate Clinical Strategy at Boston Scientific and a Research Scientist at ZOLL Medical Corporation. Notable academic achievements include a Ph.D. in Physiology & Biophysics with a concentration in Cardiac Electrophysiology from Case Western Reserve University, and contributions as a co-founder of TREVXA, a health and wellness startup. Throughout a career that includes significant research and mentoring experience, Sam Chai has published multiple peer-reviewed papers and developed solutions across various domains of medicine and clinical research.
This person is not in any teams
This person is not in any offices